Impact of Prior Authorization on Patient Access to Cancer Care.
Dario TrapaniLianne KraemerHope S RugoNancy U LinPublished in: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting (2023)
Prior authorization (PA) is a type of utilization review that health insurers apply to control service delivery, payments, and reimbursements of health interventions. The original stated intent of PA was to ensure high-quality standards in treatment delivery while encouraging evidence-based and cost-effective therapeutic choices. However, as currently implemented in clinical practice, PA has been shown to affect the health workforce, adding administrative burden to authorize needed health interventions for patients and often requiring time-consuming peer-to-peer reviews to challenge initial denials. PA is presently required for a wide range of interventions, including supportive care medicines and other essential cancer care interventions. Patients who are denied coverage are commonly forced to receive second-choice options, including less effective or less tolerable options, or are exposed to financial toxicity because of substantial out-of-pocket expenditures, affecting patient-centric outcomes. The development of tools informed by national clinical guidelines to identify standard-of-care interventions for patients with specific cancer diagnoses and the implementation of evidence-based clinical pathways as part of quality improvement efforts of cancer centers have improved patient outcomes and may serve to establish new payment models for health insurers, thereby also reducing administrative burden and delays. The definition of a set of essential interventions and guidelines- or pathways-driven decisions could facilitate reimbursement decisions and thus reduce the need for PAs. Structural changes in how PA is applied and implemented, including a redefinition of its real need, are needed to optimize patient-centric outcomes and support high-quality care of patients with cancer.
Keyphrases
- healthcare
- quality improvement
- public health
- mental health
- physical activity
- end stage renal disease
- clinical practice
- affordable care act
- health information
- newly diagnosed
- ejection fraction
- health promotion
- chronic kidney disease
- palliative care
- patient safety
- prognostic factors
- primary care
- systematic review
- papillary thyroid
- pain management
- risk assessment
- adipose tissue
- peritoneal dialysis
- squamous cell carcinoma
- chronic pain
- insulin resistance
- human health
- randomized controlled trial
- patient reported
- climate change
- metabolic syndrome
- decision making